Clinical Trial Update: Study of the Effect of Atorvastatin for Reducing Aging-related Complication in HIV-infected Patients Older Than 45 Years Receiving a Protease Inhibitor-based Regimen Versus a Raltegravir-based Regimen [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of atorvastatin on aging-related complications in HIV-infected patients over 45 on protease inhibitor therapy versus raltegr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging-related Inflammation
• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: Aging-related Inflammation in HIV-infected Patients | Phase 4 | Status: COMPLETED | Results posted: 2020-06-22